BeOne Medicines (ONC) Change in Receivables (2017 - 2025)
Historic Change in Receivables for BeOne Medicines (ONC) over the last 9 years, with Q3 2025 value amounting to $93.9 million.
- BeOne Medicines' Change in Receivables rose 21467.77% to $93.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $293.0 million, marking a year-over-year increase of 1788.61%. This contributed to the annual value of $329.4 million for FY2024, which is 7495.09% up from last year.
- Per BeOne Medicines' latest filing, its Change in Receivables stood at $93.9 million for Q3 2025, which was up 21467.77% from $41.5 million recorded in Q2 2025.
- BeOne Medicines' Change in Receivables' 5-year high stood at $353.8 million during Q4 2021, with a 5-year trough of -$292.6 million in Q1 2022.
- In the last 5 years, BeOne Medicines' Change in Receivables had a median value of $31.9 million in 2025 and averaged $42.3 million.
- Per our database at Business Quant, BeOne Medicines' Change in Receivables skyrocketed by 26396343.28% in 2021 and then plummeted by 133670.1% in 2022.
- Quarter analysis of 5 years shows BeOne Medicines' Change in Receivables stood at $353.8 million in 2021, then tumbled by 105.48% to -$19.4 million in 2022, then surged by 330.96% to $44.8 million in 2023, then skyrocketed by 180.61% to $125.7 million in 2024, then fell by 25.28% to $93.9 million in 2025.
- Its Change in Receivables stands at $93.9 million for Q3 2025, versus $41.5 million for Q2 2025 and $31.9 million for Q1 2025.